Texas Orthopedic Hospital - Houston
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Edwards, Thomas B
NCT06461949: Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray

Withdrawn
3
132
NA
Dupilumab
National Institute on Deafness and Other Communication Disorders (NIDCD)
Allergic Fungal Rhinosinusitis (AFRS), Chronic Rhinosinusitis (CRS), Asthma, Nasal Polyps
07/24
07/24
ADAPT, NCT05545072: Add-on Dupilumab for AFRS as Postoperative Therapy

Terminated
3
5
US
Dupilumab, Dupixent, Placebo, Intranasal Corticosteroid Sprays (INCS)
Emory University, Sanofi
Allergic Fungal Rhinosinusitis
07/24
07/24
NCT04850118: A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

Recruiting
2/3
75
Europe, US, RoW
rAAV2tYF-GRK1-hRPGRco, AGTC-501, Control, Untreated Control Group
Beacon Therapeutics
X-Linked Retinitis Pigmentosa
08/25
10/29

Download Options